Structure

Physi-Chem Properties

Molecular Weight:  828.52
Volume:  838.668
LogP:  3.964
LogD:  3.747
LogS:  -3.638
# Rotatable Bonds:  11
TPSA:  225.06
# H-Bond Aceptor:  14
# H-Bond Donor:  8
# Rings:  6
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.117
Synthetic Accessibility Score:  6.156
Fsp3:  0.977
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.278
MDCK Permeability:  0.00010140395170310512
Pgp-inhibitor:  0.994
Pgp-substrate:  0.26
Human Intestinal Absorption (HIA):  0.408
20% Bioavailability (F20%):  0.011
30% Bioavailability (F30%):  0.853

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  80.09253692626953%
Volume Distribution (VD):  0.442
Pgp-substrate:  8.039217948913574%

ADMET: Metabolism

CYP1A2-inhibitor:  0.001
CYP1A2-substrate:  0.104
CYP2C19-inhibitor:  0.004
CYP2C19-substrate:  0.691
CYP2C9-inhibitor:  0.032
CYP2C9-substrate:  0.072
CYP2D6-inhibitor:  0.012
CYP2D6-substrate:  0.087
CYP3A4-inhibitor:  0.099
CYP3A4-substrate:  0.108

ADMET: Excretion

Clearance (CL):  0.948
Half-life (T1/2):  0.509

ADMET: Toxicity

hERG Blockers:  0.434
Human Hepatotoxicity (H-HT):  0.126
Drug-inuced Liver Injury (DILI):  0.106
AMES Toxicity:  0.072
Rat Oral Acute Toxicity:  0.056
Maximum Recommended Daily Dose:  0.003
Skin Sensitization:  0.344
Carcinogencity:  0.008
Eye Corrosion:  0.003
Eye Irritation:  0.009
Respiratory Toxicity:  0.46

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC57964

Natural Product ID:  NPC57964
Common Name*:   Combretaside A
IUPAC Name:   [(2R,3S,5R,8R,9R,10S,11R,13R,14R,17S)-17-[(2R)-2,6-dihydroxy-6-methylheptan-2-yl]-4,4,8,10,14-pentamethyl-2,11-bis[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
Synonyms:  
Standard InCHIKey:  LWECKXUQVPEFRN-WXVNMTHESA-N
Standard InCHI:  InChI=1S/C44H76O14/c1-21-29(46)31(48)33(50)37(54-21)57-26-19-25-24(44(11,53)16-12-15-39(4,5)52)13-17-42(25,9)43(10)18-14-28-40(6,7)36(56-23(3)45)27(20-41(28,8)35(26)43)58-38-34(51)32(49)30(47)22(2)55-38/h21-22,24-38,46-53H,12-20H2,1-11H3/t21-,22-,24+,25-,26-,27-,28+,29+,30+,31+,32+,33-,34-,35-,36-,37+,38+,41+,42-,43-,44-/m1/s1
SMILES:  CC(=O)O[C@@H]1[C@H](O[C@@H]2O[C@H](C)[C@@H]([C@@H]([C@H]2O)O)O)C[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2[C@H](O[C@@H]2O[C@H](C)[C@@H]([C@@H]([C@H]2O)O)O)C[C@H]2[C@@]1(C)CC[C@@H]2[C@@](CCCC(O)(C)C)(O)C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2419357
PubChem CID:   73350745
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001580] Triterpene glycosides
            • [CHEMONTID:0002358] Triterpene saponins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32465 combretum inflatum Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[23978065]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT19 Organism Escherichia coli Escherichia coli IC50 >= 30.0 ug.mL-1 PMID[515946]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC57964 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC94582
0.9667 High Similarity NPC203434
0.9667 High Similarity NPC238796
0.9667 High Similarity NPC237071
0.9451 High Similarity NPC296936
0.9444 High Similarity NPC191915
0.9444 High Similarity NPC151214
0.9432 High Similarity NPC131466
0.9348 High Similarity NPC470591
0.9255 High Similarity NPC476838
0.9255 High Similarity NPC476512
0.9255 High Similarity NPC476839
0.9255 High Similarity NPC472081
0.9255 High Similarity NPC475574
0.9255 High Similarity NPC108227
0.9239 High Similarity NPC252056
0.9222 High Similarity NPC210759
0.9222 High Similarity NPC229801
0.9222 High Similarity NPC307167
0.9205 High Similarity NPC43912
0.9205 High Similarity NPC140446
0.9158 High Similarity NPC470029
0.9158 High Similarity NPC134967
0.9158 High Similarity NPC114700
0.9158 High Similarity NPC310138
0.914 High Similarity NPC210157
0.913 High Similarity NPC92196
0.913 High Similarity NPC477494
0.9111 High Similarity NPC65550
0.9062 High Similarity NPC97260
0.9062 High Similarity NPC139181
0.9062 High Similarity NPC476837
0.9022 High Similarity NPC305418
0.9022 High Similarity NPC45959
0.9022 High Similarity NPC309866
0.9022 High Similarity NPC252253
0.9011 High Similarity NPC204881
0.9011 High Similarity NPC293609
0.9011 High Similarity NPC473830
0.9 High Similarity NPC82955
0.9 High Similarity NPC473472
0.8977 High Similarity NPC290612
0.8947 High Similarity NPC51579
0.8936 High Similarity NPC477222
0.8936 High Similarity NPC477223
0.8913 High Similarity NPC172838
0.8913 High Similarity NPC149400
0.8913 High Similarity NPC137004
0.8913 High Similarity NPC277774
0.8913 High Similarity NPC144790
0.8913 High Similarity NPC88962
0.8913 High Similarity NPC473726
0.8901 High Similarity NPC279329
0.8901 High Similarity NPC223143
0.8889 High Similarity NPC281004
0.8842 High Similarity NPC209798
0.8842 High Similarity NPC471375
0.8842 High Similarity NPC471374
0.883 High Similarity NPC476510
0.883 High Similarity NPC139271
0.883 High Similarity NPC304011
0.883 High Similarity NPC121453
0.883 High Similarity NPC142264
0.8817 High Similarity NPC222731
0.8817 High Similarity NPC473851
0.8817 High Similarity NPC179859
0.8817 High Similarity NPC477224
0.8817 High Similarity NPC312678
0.8817 High Similarity NPC294686
0.8817 High Similarity NPC24960
0.8817 High Similarity NPC131693
0.8817 High Similarity NPC253268
0.8817 High Similarity NPC174024
0.8817 High Similarity NPC3538
0.8817 High Similarity NPC473774
0.8817 High Similarity NPC291547
0.8817 High Similarity NPC475436
0.8817 High Similarity NPC113500
0.8804 High Similarity NPC36372
0.8804 High Similarity NPC149966
0.8804 High Similarity NPC5632
0.88 High Similarity NPC43976
0.88 High Similarity NPC51925
0.88 High Similarity NPC125361
0.88 High Similarity NPC296761
0.88 High Similarity NPC154085
0.8791 High Similarity NPC102725
0.8788 High Similarity NPC203974
0.8776 High Similarity NPC469827
0.875 High Similarity NPC471428
0.875 High Similarity NPC470030
0.875 High Similarity NPC471426
0.875 High Similarity NPC471427
0.8737 High Similarity NPC470028
0.8737 High Similarity NPC233649
0.8737 High Similarity NPC472273
0.8723 High Similarity NPC474399
0.871 High Similarity NPC234352
0.871 High Similarity NPC48339
0.871 High Similarity NPC177834
0.871 High Similarity NPC141769
0.871 High Similarity NPC167644
0.871 High Similarity NPC250393
0.871 High Similarity NPC477451
0.871 High Similarity NPC476669
0.871 High Similarity NPC325828
0.871 High Similarity NPC311246
0.871 High Similarity NPC297348
0.871 High Similarity NPC477547
0.871 High Similarity NPC249204
0.87 High Similarity NPC469826
0.87 High Similarity NPC38217
0.87 High Similarity NPC472988
0.8696 High Similarity NPC473542
0.8667 High Similarity NPC471410
0.8667 High Similarity NPC471411
0.866 High Similarity NPC477172
0.8646 High Similarity NPC292775
0.8646 High Similarity NPC473518
0.8632 High Similarity NPC473287
0.8632 High Similarity NPC473601
0.8632 High Similarity NPC195297
0.8632 High Similarity NPC156377
0.8627 High Similarity NPC65167
0.8617 High Similarity NPC291203
0.8617 High Similarity NPC175
0.8617 High Similarity NPC473503
0.8617 High Similarity NPC264101
0.8617 High Similarity NPC475325
0.8617 High Similarity NPC471464
0.8617 High Similarity NPC217205
0.8614 High Similarity NPC236753
0.8614 High Similarity NPC228190
0.8602 High Similarity NPC476668
0.8602 High Similarity NPC473637
0.86 High Similarity NPC234160
0.8587 High Similarity NPC20822
0.8557 High Similarity NPC317019
0.8557 High Similarity NPC20028
0.8544 High Similarity NPC477489
0.8542 High Similarity NPC83137
0.8542 High Similarity NPC274200
0.8542 High Similarity NPC232611
0.8542 High Similarity NPC115165
0.8542 High Similarity NPC475207
0.8542 High Similarity NPC303069
0.8542 High Similarity NPC476112
0.8542 High Similarity NPC51520
0.8542 High Similarity NPC307534
0.8542 High Similarity NPC470861
0.8542 High Similarity NPC470862
0.8526 High Similarity NPC19400
0.8526 High Similarity NPC211354
0.8526 High Similarity NPC473727
0.8526 High Similarity NPC107962
0.8526 High Similarity NPC215570
0.8526 High Similarity NPC473064
0.8526 High Similarity NPC473067
0.8526 High Similarity NPC473065
0.8526 High Similarity NPC206003
0.8526 High Similarity NPC6295
0.8526 High Similarity NPC107188
0.8526 High Similarity NPC473610
0.8526 High Similarity NPC469710
0.8526 High Similarity NPC475351
0.8515 High Similarity NPC472079
0.8511 High Similarity NPC182740
0.8511 High Similarity NPC256104
0.8511 High Similarity NPC122083
0.8511 High Similarity NPC224003
0.8511 High Similarity NPC171741
0.8511 High Similarity NPC211845
0.8511 High Similarity NPC470623
0.8511 High Similarity NPC18724
0.8511 High Similarity NPC323231
0.85 High Similarity NPC473199
0.8462 Intermediate Similarity NPC477283
0.8462 Intermediate Similarity NPC155531
0.8462 Intermediate Similarity NPC215968
0.8454 Intermediate Similarity NPC157739
0.8454 Intermediate Similarity NPC473638
0.8454 Intermediate Similarity NPC473616
0.8454 Intermediate Similarity NPC291548
0.8447 Intermediate Similarity NPC469824
0.8438 Intermediate Similarity NPC232037
0.8438 Intermediate Similarity NPC128572
0.8438 Intermediate Similarity NPC475625
0.8438 Intermediate Similarity NPC470864
0.8438 Intermediate Similarity NPC132080
0.8438 Intermediate Similarity NPC470863
0.8438 Intermediate Similarity NPC284104
0.8438 Intermediate Similarity NPC160426
0.8438 Intermediate Similarity NPC287483
0.8438 Intermediate Similarity NPC470866
0.8438 Intermediate Similarity NPC472989
0.8438 Intermediate Similarity NPC98018
0.8438 Intermediate Similarity NPC30856
0.8438 Intermediate Similarity NPC97700
0.8438 Intermediate Similarity NPC116756
0.8438 Intermediate Similarity NPC103616

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC57964 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.871 High Similarity NPD8171 Discontinued
0.8218 Intermediate Similarity NPD8170 Clinical (unspecified phase)
0.7944 Intermediate Similarity NPD8133 Approved
0.7838 Intermediate Similarity NPD8377 Approved
0.7838 Intermediate Similarity NPD8294 Approved
0.7768 Intermediate Similarity NPD8033 Approved
0.7768 Intermediate Similarity NPD8296 Approved
0.7768 Intermediate Similarity NPD8380 Approved
0.7768 Intermediate Similarity NPD8379 Approved
0.7768 Intermediate Similarity NPD8335 Approved
0.7768 Intermediate Similarity NPD8378 Approved
0.7609 Intermediate Similarity NPD6928 Phase 2
0.7589 Intermediate Similarity NPD7516 Approved
0.757 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7328 Approved
0.75 Intermediate Similarity NPD7327 Approved
0.7368 Intermediate Similarity NPD3670 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD3669 Approved
0.7273 Intermediate Similarity NPD4267 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD6118 Approved
0.7204 Intermediate Similarity NPD6115 Approved
0.7204 Intermediate Similarity NPD6114 Approved
0.7204 Intermediate Similarity NPD6697 Approved
0.7168 Intermediate Similarity NPD6940 Discontinued
0.7155 Intermediate Similarity NPD7503 Approved
0.7143 Intermediate Similarity NPD1810 Approved
0.7143 Intermediate Similarity NPD1811 Approved
0.7097 Intermediate Similarity NPD6116 Phase 1
0.7059 Intermediate Similarity NPD7507 Approved
0.7 Intermediate Similarity NPD7532 Clinical (unspecified phase)
0.6989 Remote Similarity NPD6117 Approved
0.6891 Remote Similarity NPD8328 Phase 3
0.6885 Remote Similarity NPD7319 Approved
0.6813 Remote Similarity NPD2254 Approved
0.6813 Remote Similarity NPD2686 Approved
0.6813 Remote Similarity NPD2687 Approved
0.6774 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6762 Remote Similarity NPD7991 Discontinued
0.6757 Remote Similarity NPD6412 Phase 2
0.6667 Remote Similarity NPD7736 Approved
0.6635 Remote Similarity NPD8034 Phase 2
0.6635 Remote Similarity NPD8035 Phase 2
0.6633 Remote Similarity NPD1779 Approved
0.6633 Remote Similarity NPD1780 Approved
0.6549 Remote Similarity NPD8174 Phase 2
0.6549 Remote Similarity NPD6686 Approved
0.6517 Remote Similarity NPD371 Approved
0.6452 Remote Similarity NPD8293 Discontinued
0.6404 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6383 Remote Similarity NPD4808 Clinical (unspecified phase)
0.6383 Remote Similarity NPD4809 Clinical (unspecified phase)
0.6373 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6354 Remote Similarity NPD3703 Phase 2
0.6354 Remote Similarity NPD3702 Approved
0.6324 Remote Similarity NPD7625 Phase 1
0.6277 Remote Similarity NPD4787 Phase 1
0.6273 Remote Similarity NPD7638 Approved
0.626 Remote Similarity NPD6370 Approved
0.6216 Remote Similarity NPD7639 Approved
0.6216 Remote Similarity NPD7640 Approved
0.6207 Remote Similarity NPD4061 Clinical (unspecified phase)
0.62 Remote Similarity NPD7525 Registered
0.6186 Remote Similarity NPD6882 Approved
0.6186 Remote Similarity NPD8297 Approved
0.6179 Remote Similarity NPD8513 Phase 3
0.6179 Remote Similarity NPD8516 Approved
0.6179 Remote Similarity NPD8517 Approved
0.6179 Remote Similarity NPD8515 Approved
0.617 Remote Similarity NPD3699 Clinical (unspecified phase)
0.617 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6161 Remote Similarity NPD1700 Approved
0.616 Remote Similarity NPD7492 Approved
0.6116 Remote Similarity NPD6009 Approved
0.6111 Remote Similarity NPD6616 Approved
0.6106 Remote Similarity NPD7632 Discontinued
0.6098 Remote Similarity NPD6054 Approved
0.6098 Remote Similarity NPD6319 Approved
0.6098 Remote Similarity NPD6059 Approved
0.6077 Remote Similarity NPD8449 Approved
0.6071 Remote Similarity NPD8418 Phase 2
0.6064 Remote Similarity NPD5360 Phase 3
0.6064 Remote Similarity NPD5361 Clinical (unspecified phase)
0.6063 Remote Similarity NPD7078 Approved
0.6042 Remote Similarity NPD6081 Approved
0.6042 Remote Similarity NPD5777 Approved
0.6031 Remote Similarity NPD8450 Suspended
0.6017 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6 Remote Similarity NPD4632 Approved
0.6 Remote Similarity NPD4057 Clinical (unspecified phase)
0.6 Remote Similarity NPD4056 Clinical (unspecified phase)
0.5965 Remote Similarity NPD8084 Approved
0.5965 Remote Similarity NPD8086 Approved
0.5965 Remote Similarity NPD8083 Approved
0.5965 Remote Similarity NPD8139 Approved
0.5965 Remote Similarity NPD8082 Approved
0.5965 Remote Similarity NPD8085 Approved
0.5965 Remote Similarity NPD8138 Approved
0.5948 Remote Similarity NPD6402 Approved
0.5948 Remote Similarity NPD6675 Approved
0.5948 Remote Similarity NPD7128 Approved
0.5948 Remote Similarity NPD5739 Approved
0.5943 Remote Similarity NPD7524 Approved
0.5938 Remote Similarity NPD4244 Approved
0.5938 Remote Similarity NPD4245 Approved
0.5938 Remote Similarity NPD4789 Approved
0.5932 Remote Similarity NPD6372 Approved
0.5932 Remote Similarity NPD6373 Approved
0.592 Remote Similarity NPD6015 Approved
0.592 Remote Similarity NPD6016 Approved
0.592 Remote Similarity NPD6921 Approved
0.5913 Remote Similarity NPD8276 Approved
0.5913 Remote Similarity NPD8275 Approved
0.5909 Remote Similarity NPD7748 Approved
0.5897 Remote Similarity NPD7646 Clinical (unspecified phase)
0.5893 Remote Similarity NPD7902 Approved
0.5873 Remote Similarity NPD5988 Approved
0.5862 Remote Similarity NPD8081 Approved
0.5854 Remote Similarity NPD7115 Discovery
0.5851 Remote Similarity NPD4224 Phase 2
0.5847 Remote Similarity NPD6899 Approved
0.5847 Remote Similarity NPD6881 Approved
0.5847 Remote Similarity NPD7320 Approved
0.5833 Remote Similarity NPD6650 Approved
0.5833 Remote Similarity NPD3698 Phase 2
0.5833 Remote Similarity NPD8413 Clinical (unspecified phase)
0.5833 Remote Similarity NPD8130 Phase 1
0.5833 Remote Similarity NPD6649 Approved
0.5827 Remote Similarity NPD6067 Discontinued
0.5824 Remote Similarity NPD6123 Approved
0.5818 Remote Similarity NPD6399 Phase 3
0.5812 Remote Similarity NPD8393 Approved
0.5784 Remote Similarity NPD7645 Phase 2
0.5763 Remote Similarity NPD5954 Clinical (unspecified phase)
0.5763 Remote Similarity NPD5697 Approved
0.5763 Remote Similarity NPD5701 Approved
0.5763 Remote Similarity NPD8140 Approved
0.5763 Remote Similarity NPD8307 Discontinued
0.575 Remote Similarity NPD6883 Approved
0.575 Remote Similarity NPD7102 Approved
0.575 Remote Similarity NPD7290 Approved
0.5745 Remote Similarity NPD3171 Clinical (unspecified phase)
0.5727 Remote Similarity NPD7515 Phase 2
0.5714 Remote Similarity NPD4758 Discontinued
0.5703 Remote Similarity NPD7604 Phase 2
0.5702 Remote Similarity NPD6847 Approved
0.5702 Remote Similarity NPD6617 Approved
0.5702 Remote Similarity NPD6869 Approved
0.5701 Remote Similarity NPD8308 Discontinued
0.5686 Remote Similarity NPD3671 Phase 1
0.5686 Remote Similarity NPD5364 Discontinued
0.5669 Remote Similarity NPD5983 Phase 2
0.5667 Remote Similarity NPD8306 Approved
0.5667 Remote Similarity NPD8305 Approved
0.5667 Remote Similarity NPD6012 Approved
0.5667 Remote Similarity NPD6013 Approved
0.5667 Remote Similarity NPD6014 Approved
0.566 Remote Similarity NPD7338 Clinical (unspecified phase)
0.5649 Remote Similarity NPD6033 Approved
0.5641 Remote Similarity NPD7912 Approved
0.5641 Remote Similarity NPD7986 Approved
0.5641 Remote Similarity NPD7987 Approved
0.5641 Remote Similarity NPD7911 Approved
0.5636 Remote Similarity NPD6701 Clinical (unspecified phase)
0.5636 Remote Similarity NPD6700 Approved
0.5631 Remote Similarity NPD7329 Approved
0.5625 Remote Similarity NPD7900 Approved
0.5625 Remote Similarity NPD7901 Clinical (unspecified phase)
0.562 Remote Similarity NPD8087 Discontinued
0.5615 Remote Similarity NPD6336 Discontinued
0.5614 Remote Similarity NPD6084 Phase 2
0.5614 Remote Similarity NPD6083 Phase 2
0.5603 Remote Similarity NPD5344 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data